@lungs4living.bsky.social
Sandra's paper is out in Science! So pleased. Thank you to all the authors, contributors and patients that have been with us on this journey. @science.org @sandra-gl.bsky.social Aberrant basal cell clonal dynamics shape early lung carcinogenesis
www.science.org/doi/full/10....
www.science.org/doi/full/10....
www.science.org
May 2, 2025 at 1:13 PM
Sandra's paper is out in Science! So pleased. Thank you to all the authors, contributors and patients that have been with us on this journey. @science.org @sandra-gl.bsky.social Aberrant basal cell clonal dynamics shape early lung carcinogenesis
www.science.org/doi/full/10....
www.science.org/doi/full/10....
Reposted
While progress has been made in treating #NSCLC, patients would further benefit from earlier detection & effective interception. Here, Spira and colleagues explore advances in identifying premalignant lesions, and devise approaches for stratification + interventions.
https://bit.ly/3QE86...
https://bit.ly/3QE86...
Translating premalignant biology to accelerate non-small-cell lung cancer interception - Nature Reviews Cancer
While progress has been made in treating advanced non-small-cell lung cancer, patients would further benefit from methods that detect progressive premalignant lesions and strategies that effectively intercept progression. In this Review, Mazzilli et al. explore recent advances in identifying...
bit.ly
March 3, 2025 at 3:41 PM
While progress has been made in treating #NSCLC, patients would further benefit from earlier detection & effective interception. Here, Spira and colleagues explore advances in identifying premalignant lesions, and devise approaches for stratification + interventions.
https://bit.ly/3QE86...
https://bit.ly/3QE86...
Congratulation to the SUMMIT team on our publication in Lancet Oncology today: Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study.
authors.elsevier.com/sd/article/S...
authors.elsevier.com/sd/article/S...
March 26, 2025 at 5:46 PM
Congratulation to the SUMMIT team on our publication in Lancet Oncology today: Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study.
authors.elsevier.com/sd/article/S...
authors.elsevier.com/sd/article/S...